Systematische Übersichtsarbeit: aortale Komplikationen nach intravesikaler Bacillus Calmette-Guérin-Behandlung

Zusammenfassung

Hintergrund Aortale Pathologien nach intravesikaler BCG-Applikation (BCG: Bacillus Calmette-Guérin) stellen eine seltene Komplikation nach der Behandlung von nicht muskelinvasiven Harnblasentumoren dar. Das Ziel dieser Studie war es, eine deskriptive Analyse der bisher publizierten Studien im Rahmen einer systematischen Übersichtsarbeit durchzuführen und die besonderen Herausforderungen der Diagnosestellung und Behandlung dieser seltenen Komplikation zu diskutieren.

Material und Methode Es erfolgte eine Literaturrecherche in den Datenbanken PubMed (1949–2021) und Web of Science (1900–2021) mit den Suchtermini „mycobacterium“ OR „bovis“ OR „BCG“ AND „aorta“ OR „aneurysm“. In einem stufenweisen Bewertungsverfahren wurden Publikationen mit folgenden Einschlusskriterien in die finale Datenauswertung eingeschlossen: Originalarbeit, Volltextverfügbarkeit in englischer oder deutscher Sprache und aortale Komplikation nach intravesikaler BCG-Instillation.

Ergebnisse In 55 publizierten Arbeiten wurden insgesamt 60 Einzelfälle beschrieben. BCG-induzierte, mykotische Aortenaneurysmen können in allen Segmenten der Aorta auftreten, wobei das infrarenale Aortensegment am häufigsten betroffen war (65% aller Fälle). Häufig handelte es sich um sakkuläre (65%) Aussackungen mit (28%) oder ohne Aortenruptur (63%). Begleitinfektionen in anderweitigen Geweben waren typisch (65%). Die Diagnose beruhte auf der Kombination aus pathologischen und mikrobiologischen Analysemethoden. Ein gängiger Therapiealgorithmus war die chirurgische Infektsanierung (85%) und die antimykobakterielle Therapie (83%). Gleichzeitig durchgeführt führten sie zu einem Langzeitüberleben von 81%. Eine Protheseninfektion nach initialem Aortenrepair mit alloplastischem Material (n = 40) entwickelte sich im Verlauf bei 10 Patienten (25%).

Diskussion Die Diagnosestellung beruht auf der Probengewinnung jeglichen infizierten Gewebes und der Kombination aus passender Anamnese, Klinik und Laboranalysen. Die Kombination aus chirurgischer Infektsanierung und pharmakologischer Begleittherapie scheint die besten Ergebnisse zu erzielen. Bereits bei der Initialoperation sollte die Möglichkeit eines autologen oder allogenen Aortenersatzes evaluiert werden, da das Risiko eines Protheseninfektes nach Verwendung alloplastischer Materialien hoch ist.

Abstract

Background Aortic complications after intravesical Bacillus Calmette-Guérin (BCG) application are a rare complication of the treatment of non-muscle invasive bladder cancer. The aim of this systematic review was to perform a descriptive analysis of previously published studies and to discuss the particular challenges of diagnosis and treatment of this rare complication.

Material and Methods A literature search was performed in PubMed (1949–2021) and Web of Science (1900–2021) using the search terms “mycobacterium” OR “bovis” OR “BCG” AND “aorta” OR “aneurysm”. In a staged review process, publications with the following inclusion criteria were included in data analysis: original paper, full-text availability in English or German and aortic complication after intravesical BCG instillation. We focused on the analysis of BCG-specific medical history data as well as treatment strategies in relation to patient outcome and the occurrence of graft infections during follow-up.

Results A total of 60 individual cases were described in 55 published articles. BCG-induced mycotic aortic aneurysms can occur in all segments of the thoracoabdominal aorta, but the infrarenal aortic segment was most commonly affected (65% of cases). The most common configuration was saccular outpouchings (65%). Concomitant infections in other tissues were typical (65%). Patients with mycotic aneurysm presented with or without consecutive aortic rupture in 28% and 63%, respectively. Diagnosis was based on a combination of pathological and microbiological examinations. A common treatment algorithm was surgical infection treatment (85%) and antitubercular therapy (83%). Performed simultaneously, they resulted in a long-term survival of 81%. Graft infection after initial aortic repair with alloplastic material (n = 40) developed in ten patients (25%) during follow-up.

Discussion Diagnosis of mycotic aneurysms or vascular complications after intravesical BCG application is exceptionally challenging and a high level of suspicion is required. Diagnosis is based on obtaining sample material of affected regions and the combination of patient’s history, clinical presentation and pathological or microbiological examinations. Currently, no consensus guideline for optimal medical treatment options of aortic complications secondary to BCG instillation exists. The combination of surgical treatment and supportive antitubercular therapy seems to achieve the best results. Since the risk of prosthetic infection after the use of alloplastic materials remains high (25%), we strongly suggest evaluating autologous or allogenic aortic replacement during initial aortic repair.

Schlüsselwörter

Aortenaneurysma - mykotisches Aortenaneurysma - Mycobacterium bovis - BCG - Harnblasenkarzinom - systematische Übersichtsarbeit

Keywords

mycotic aneurysm - mycobacterium bovis - BCG - bladder cancer - systematic review - Aortic aneurysm

Publication History

Received: 23 May 2021

Accepted after revision: 08 August 2021

Article published online:
19 October 2021

• Literatur

• 1 Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 1976; 116: 180-183
• 2 Babjuk M, Böhle A, Burger M. et al. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017; 71: 447-461
• 3 Prescott S, Jackson AM, Hawkyard SJ. et al. Mechanisms of action of intravesical bacille Calmette-Guérin: local immune mechanisms. Clin Infect Dis 2000; 31 (Suppl. 03) S91-S93
• 4 Lamm DL. Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer. Clin Infect Dis 2000; 31 (Suppl. 03) S86-S90
• 5 Lamm DL, van der Meijden PM, Morales A. et al. Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol 1992; 147: 596-600
• 6 Sharma V, Thakur APS, Ramasamy V. et al. Complications of intravesical BCG therapy in non-muscle invasive bladder cancer: our tertiary care centre experience. Afr J Urol 2020; 26: 90
• 7 Pérez-Jacoiste Asín MA, Fernández-Ruiz M, López-Medrano F. et al. Bacillus Calmette-Guerin (BCG) Infection Following Intravesical BCG Administration as Adjunctive Therapy For Bladder Cancer Incidence, Risk Factors, and Outcome in a Single-Institution Series and Review of the Literature. Medicine (Baltimore) 2014; 93: 236-254
• 8 Oderich GS, Panneton JM, Bower TC. et al. Infected aortic aneurysms: aggressive presentation, complicated early outcome, but durable results. J Vasc Surg 2001; 34: 900-908
• 9 Müller BT, Wegener OR, Grabitz K. et al. Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extra-anatomic repair in 33 cases. J Vasc Surg 2001; 33: 106-113
• 10 Dubois M, Daenens K, Houthoofd S. et al. Treatment of mycotic aneurysms with involvement of the abdominal aorta: single-centre experience in 44 consecutive cases. Eur J Vasc Endovasc Surg 2010; 40: 450-456
• 11 Long R, Guzman R, Greenberg H. et al. Tuberculous mycotic aneurysm of the aorta: review of published medical and surgical experience. Chest 1999; 115: 522-531
• 12 Page MJ, McKenzie JE, Bossuyt PM. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71
• 13 Murad MH, Sultan S, Haffar S. et al. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med 2018; 23: 60-63
• 14 Akabane K, Uchida T, Matsuo S. et al. Hybrid operation for infectious thoracic and abdominal aortic aneurysms complicated with Bacillus Calmette-Guérin therapy for bladder cancer: A case report. Medicine (Baltimore) 2021; 100: e24796
• 15 Akita H, Okamura T, Nakane A. et al. Infectious aortic aneurysms occurring 1 year after bacillus Calmette-Guerin bladder instillation therapy. Int J Urol 2015; 22: 234-235
• 16 Berchiolli R, Mocellin DM, Marconi M. et al. Ruptured Mycotic Aneurysm After Intravesical Instillation for Bladder Tumor. Ann Vasc Surg 2019; 59: 310.e7-310.e11
• 17 Buerger M, Kapahnke S, Omran S. et al. Aortic aneurysm and aortic graft infection related to Mycobacterium bovis after intravesical Bacille Calmette-Guérin therapy-a case series. BMC Surg 2021; 21: 138
• 18 Coddington ND, Sandberg JK, Yang C. et al. Mycotic Aneurysm after Bacillus Calmette-Guérin Treatment: Case Report and Review of the Literature. Case Rep Urol 2017; 2017: 4508583
• 19 Coscas R, Arlet JB, Belhomme D. et al. Multiple mycotic aneurysms due to Mycobacterium bovis after intravesical bacillus Calmette-Guerin therapy. J Vasc Surg 2009; 50: 1185-1190
• 20 Costiniuk CT, Sharapov AA, Rose GW. et al. Mycobacterium bovis abdominal aortic and femoral artery aneurysms following intravesical bacillus Calmette-Guérin therapy for bladder cancer. Cardiovasc Pathol 2010; 19: e29-e32
• 21 Damm O, Briheim G, Hagstrom T. et al. Ruptured mycotic aneurysm of the abdominal aorta: A serious complication of intravesical instillation bacillus Calmette-Guerin therapy. J Urol 1998; 159: 984-984
• 22 Darriet F, Bernioles P, Loukil A. et al. Fluorescence in situ hybridization microscopic detection of Bacilli Calmette Guerin mycobacteria in aortic lesions: A case report. Medicine (Baltimore) 2018; 97: e11321
• 23 Davis FM, Miller DJ, Newton D. et al. Successful Treatment of a Mycotic Multifocal Thoracoabdominal Aortic Aneurysm as a Late Sequelae of Intravesical Bacillus Calmette-Guerin Therapy: Case Report and Literature Review. Ann Vasc Surg 2015; 29: 840.e9-840.e13
• 24 Deresiewicz RL, Stone RM, Aster JC. Fatal disseminated mycobacterial infection following intravesical bacillus Calmette-Guerin. J Urol 1990; 144: 1331-1333
• 25 Dubert M, Abihssira S, Diamantis S. et al. Mycobacterium bovisinfection of an aortobifemoral bypass graft withStreptococcus intermediussuperinfection after intravesical bacillus Calmette-Guerin immunotherapy for bladder cancer. Infection 2021; 49: 345-348
• 26 Farber A, Grigoryants V, Palac DM. et al. Primary aortoduodenal fistula in a patient with a history of intravesical therapy for bladder cancer with bacillus Calmette-Guérin: review of primary aortoduodenal fistula without abdominal aortic aneurysm. J Vasc Surg 2001; 33: 868-873
• 27 Floros N, Meletiadis K, Kusenack U. et al. Ruptured Mycotic Aortic Aneurysm after Bacille Calmette-Guerin Therapy. Ann Vasc Surg 2015; 29: 1450.e1-1450.e4
• 28 Gao CQ, Mithani R, Leya J. et al. Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guerin therapy: Case report. BMC Infect Dis 2011; 11: 260
• 29 Hakim S, Heaney JA, Heinz T. et al. Psoas abscess following intravesical bacillus Calmette-Guerin for bladder cancer: a case report. J Urol 1993; 150: 188-189
• 30 Harding GE, Lawlor DK. Ruptured mycotic abdominal aortic aneurysm secondary to Mycobacterium bovis after intravesical treatment with bacillus Calmette-Guérin. J Vasc Surg 2007; 46: 131-134
• 31 Hellinger WC, Oldenburg WA, Alvarez S. Vascular and other serious infections with Mycobacterium bovis after bacillus of Calmette-Guérin therapy for bladder cancer. South Med J 1995; 88: 1212-1216
• 32 Hellmann DB, Shepard JO, Schaefer PW. et al. Case 5–2021: A 68-Year-Old Man with Delirium and Renal Insufficiency. N Engl J Med 2021; 384: 651-662
• 33 Higashi Y, Nakamura S, Kidani K. et al. Mycobacterium bovis-induced Aneurysm after Intravesical Bacillus Calmette-Guerin Therapy: A Case Study and Literature Review. Intern Med 2018; 57: 429-435
• 34 Holmes BJ, LaRue RW, Black JH. et al. Mycotic aortic aneurysm due to intravesical BCG immunotherapy: Clinical manifestations and diagnostic challenges. Int J Mycobacteriol 2014; 3: 60-65
• 35 Hui DS, Stoeckel DA, Kaufman EE. et al. Massive Hemoptysis From an Aortobronchial Fistula Secondary to BCG-Related Mycotic Thoracic Aortic Aneurysm. Ann Thorac Surg 2016; 101: 350-352
• 36 Izes JK, Bihrle W, Thomas CB. Corticosteroid-associated fatal mycobacterial sepsis occurring 3 years after instillation of intravesical bacillus Calmette-Guerin. J Urol 1993; 150: 1498-1500
• 37 Kamphuis JT, Buiting AG, Miseré JF. et al. BCG immunotherapy: be cautious of granulomas. Disseminated BCG infection and mycotic aneurysm as late complications of intravesical BCG instillations. Neth J Med 2001; 58: 71-75
• 38 Khandelwal A, Gupta A, Virmani V. et al. Ruptured Aortic Aneurysm Secondary to Psoas abscess after Intravesical Bacilli Calmette-Guérin. Med J Malaysia 2012; 67: 534-535
• 39 Koterazawa S, Watanabe J, Uemura Y. et al. A case of infectious thoracic aortic aneurysm after intravesical Bacillus Calmette-Guérin instillation therapy for a superficial bladder cancer. Urol Case Rep 2021; 36: 101574
• 40 Kusakabe T, Endo K, Nakamura I. et al. Bacille Calmette-Guerin (BCG) spondylitis with adjacent mycotic aortic aneurysm after intravesical BCG therapy: a case report and literature review. BMC Infect Dis 2018; 18: 290
• 41 LaBerge JM, Kerlan RK, Reilly LM. et al. Case 9: Mycotic pseudoaneurysm of the abdominal aorta in association with mycobacterial psoas abscess – A complication of BCG therapy. Radiology 1999; 211: 81-85
• 42 Lareyre F, Reverso-Meinietti J, Carboni J. et al. Mycotic Aortic Aneurysm and Infected Aortic Graft After Intravesical Bacillus Calmette-Guérin Treatment for Bladder Cancer. Vasc Endovascular Surg 2019; 53: 86-91
• 43 Leo E, Molinari ALC, Rossi G. et al. Mycotic Abdominal Aortic Aneurysm after Adjuvant Therapy with Bacillus Calmette-Guerin in Patients with Urothelial Bladder Cancer: A Rare but Misinterpreted Complication. Ann Vasc Surg 2015; 29: 1318.e1-1318.e6
• 44 Maundrell J, Fletcher S, Roberts P. et al. Mycotic aneurysm of the aorta as a complication of Bacillus Calmette-Guérin instillation. J R Coll Physicians Edinb 2011; 41: 114-116
• 45 Mizoguchi H, Iida O, Dohi T. et al. Abdominal Aortic Aneurysmal and Endovascular Device Infection With Iliopsoas Abscess Caused by Mycobacterium Bovis as a Complication of Intravesical Bacillus Calmette-Guerin Therapy. Ann Vasc Surg 2013; 27: 1186.e1-1186.e5
• 46 van Moorselaar RJA, Wisselink W. Case Presentation: Mycotic Aortic Aneurysm and Psoas Abscess as a Complication of Bacillus Calmette-Guérin Instillations. Eur Urol Focus 2016; 2: 351-353
• 47 Nam EY, Na SH, Kim SY. et al. Infected Aortic Aneurysm caused by Mycobacterium bovis after Intravesical Bacillus Calmette-Guerin Treatment for Bladder Cancer. Infect Chemother 2015; 47: 256-260
• 48 Okon E, Stearns J, Durgam AK. Tuberculous Psoas Abscess and Worsening Vascular Aneurysm; All from Bacillus Calmette-Guerin (BCG) Therapy?. Am J Case Rep 2017; 18: 810-812
• 49 Pittman M, Sakai L, Craig R. et al. Primary aortoenteric fistula following disseminated bacillus Calmette-Guerin infection: a case report. Vascular 2012; 20: 221-224
• 50 Psoinos CM, Simons JP, Baril DT. et al. A Mycobacterium bovis Mycotic Abdominal Aortic Aneurysm Resulting From Bladder Cancer Treatment, Resection, and Reconstruction With a Cryopreserved Aortic Graft. Vasc Endovascular Surg 2013; 47: 61-64
• 51 Ribeiro L, Rajendran S, Stenson K. et al. Rare case of a proximal descending thoracic aorta mycotic aneurysm following intravesical BCG injections for the treatment of bladder cancer. BMJ Case Rep 2019; 12: e231595
• 52 Roeke T, Hovsibian S, Schlejen PM. et al. A mycotic aneurysm of the abdominal aorta caused by Mycobacterium bovis after intravesical instillation with bacillus Calmette-Guerin. J Vasc Surg Cases Innov Tech 2018; 4: 122-125
• 53 Rohailla S, Kitchlu A, Wheatcroft M. et al. Mycotic aneurysm formation after bacillus Calmette-Guerin instillation for recurrent bladder cancer. CMAJ 2018; 190: E467-E471
• 54 Roylance A, Mosley J, Jameel M. et al. Aorto-enteric fistula development secondary to mycotic abdominal aortic aneurysm following intravesical bacillus Calmette-Guerin (BCG) treatment for transitional cell carcinoma of the bladder. Int J Surg Case Rep 2013; 4: 88-90
• 55 Rozenblit A, Wasserman E, Marin ML. et al. Infected aortic aneurysm and vertebral osteomyelitis after intravesical bacillus Calmette-Guérin therapy. AJR Am J Roentgenol 1996; 167: 711-713
• 56 Safdar N, Abad CL, Kaul DR. et al. An unintended consequence. N Engl J Med 2008; 358: 1496-1501
• 57 Samadian S, Phillips FM, Deeab D. Mycobacterium bovis vertebral osteomyelitis and discitis with adjacent mycotic abdominal aortic aneurysm caused by intravesical BCG therapy: a case report in an elderly gentleman. Age Ageing 2013; 42: 129-131
• 58 Santbergen B, Vriens PH, de Lange WC. et al. Combined infection of vertebroplasty and aortic graft after intravesical BCG treatment. BMJ Case Rep 2013; 2013: bcr2012008161
• 59 Seastedt KP, Ahmad U, Lau C. et al. Mycotic Thoracic Aortic Aneurysm After Intravesical Bacillus Calmette-Guerin Treatment. Ann Thorac Surg 2015; 99: 2210-2212
• 60 Seelig MH, Oldenburg WA, Klingler PJ. et al. Mycotic vascular infections of large arteries with Mycobacterium bovis after intravesical bacillus Calmette-Guérin therapy: case report. J Vasc Surg 1999; 29: 377-381
• 61 Simar J, Belkhir L, Tombal B. et al. Ruptured aortic aneurysm due to Mycobacterium bovis BCG with a delayed bacteriological diagnosis due to false negative result of the MPB 64 immunochromatographic assay. BMC Res Notes 2017; 10: 64
• 62 Smith DM. BCG-osis following intravesical BCG treatment leading to miliary pulmonary nodules, penile granulomas and a mycotic aortic aneurysm. BMJ Case Rep 2016; 2016: bcr2016215635
• 63 Ventosa-Fernandez G, Milisenda JC, Pereda D. et al. Infected False Aneurysm of the Aortic Arch After Endoscopic Transurethral Instillation of Bacillus Calmette-Guerin. Ann Thorac Surg 2015; 100: 717-720
• 64 Vudatha V, Ranson M, Blair L. et al. Rapid detection of bacille Calmette-Guerin-associated mycotic aortic aneurysm using novel cell-free DNA assay. J Vasc Surg Cases Innov Tech 2019; 5: 143-148
• 65 Wada S, Watanabe Y, Shiono N. et al. Tuberculous abdominal aortic pseudoaneurysm penetrating the left psoas muscle after BCG therapy for bladder cancer. Cardiovasc Surg 2003; 11: 231-235
• 66 Wadhwani A, Moore RD, Bakshi D. et al. Mycotic aortic aneurysms post-Intravesical BCG treatment for early-stage bladder carcinoma. CVIR Endovasc 2018; 1: 28
• 67 Walkty A, Koulack J, Milligan B. et al. An 81-year-old Male With a Pulsatile Abdominal Mass. Clin Infect Dis 2019; 69: 1456-1459
• 68 Wolf YG, Wolf DG, Higginbottom PA. et al. Infection of a ruptured aortic aneurysm and an aortic graft with bacille Calmette-Guérin after intravesical administration for bladder cancer. J Vasc Surg 1995; 22: 80-84
• 69 Boorjian SA, Zhu F, Herr HW. The effect of gender on response to bacillus Calmette-Guérin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder. BJU Int 2010; 106: 357-361
• 70 Buerger M, Frese JP, Kapahnke S. et al. Graft preservation with multi-stage surgical repair of an aortoesophageal fistula after thoracic endovascular aortic repair – A case report. Int J Surg Case Rep 2020; 72: 153-155
• 71 Omran S, Raude B, Bürger M. et al. Aortoduodenal fistulas after endovascular abdominal aortic aneurysm repair and open aortic repair. J Vasc Surg 2021;
• 72 Sörelius K, di Summa PG. On the Diagnosis of Mycotic Aortic Aneurysms. Clin Med Insights Cardiol 2018; 12: 1179546818759678
• 73 Elkabani M, Greene JN, Vincent AL. et al. Disseminated Mycobacterium bovis after intravesicular bacillus calmette-Guérin treatments for bladder cancer. Cancer Control 2000; 7: 476-481
• 74 Talbot EA, Williams DL, Frothingham R. PCR identification of Mycobacterium bovis BCG. J Clin Microbiol 1997; 35: 566-569
• 75 Sörelius K, Wanhainen A, Wahlgren CM. et al. Nationwide Study on Treatment of Mycotic Thoracic Aortic Aneurysms. Eur J Vasc Endovasc Surg 2019; 57: 239-246
• 76 LoBue PA, Moser KS. Treatment of Mycobacterium bovis infected tuberculosis patients: San Diego County, California, United States, 1994–2003. Int J Tuberc Lung Dis 2005; 9: 333-338